Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil PCIA for perioperative multimodal analgesia after kidney transplantation
ChiCTR2400091724Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Oliceridine group with Sufentanil group (2 arms). Primary endpoint: Effective rate of PCIA analgesia at 24 hours after surgery. Started Sep 2024; status: recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400091724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091724.